| Chugai Pharmaceutical (CHGCY) |
Japan |
$86.554B |
32.88 |
| Zoetis (ZTS) |
United States |
$52.072B |
18.64 |
| Takeda Pharmaceutical (TAK) |
Japan |
$45.248B |
9.23 |
| Daiichi Sankyo, - (DSNKY) |
Japan |
$41.676B |
20.75 |
| BeOne Medicines - (ONC) |
Switzerland |
$38.701B |
189.82 |
| Sandoz Group AG (SDZNY) |
Switzerland |
$32.089B |
0.00 |
| United Therapeutics (UTHR) |
United States |
$20.646B |
18.17 |
| Merck (MKKGY) |
Germany |
$17.926B |
11.05 |
| Neurocrine Biosciences (NBIX) |
United States |
$15.453B |
37.08 |
| Shionogi (SGIOY) |
Japan |
$14.530B |
13.34 |
| Summit Therapeutics (SMMT) |
United States |
$14.363B |
0.00 |
| Ionis Pharmaceuticals (IONS) |
United States |
$13.203B |
0.00 |
| Madrigal Pharmaceuticals (MDGL) |
United States |
$12.913B |
0.00 |
| IPSEN (IPSEY) |
France |
$11.771B |
0.00 |
| Orion OYJ (ORINY) |
Finland |
$9.922B |
28.35 |
| Corcept Therapeutics (CORT) |
United States |
$8.729B |
94.29 |
| Eisai (ESAIY) |
|
$8.679B |
0.00 |
| Stevanato Group S.p.A (STVN) |
Italy |
$6.505B |
36.41 |
| Ono Pharmaceutical (OPHLF) |
Japan |
$6.238B |
18.97 |
| Grifols, S.A (GRFS) |
Spain |
$6.174B |
0.00 |
| Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$4.620B |
0.00 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$4.498B |
0.00 |
| NewAmsterdam Pharma (NAMS) |
Netherlands |
$4.054B |
0.00 |
| Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$3.965B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$3.731B |
17.72 |
| Ocular Therapeutix (OCUL) |
United States |
$3.432B |
0.00 |
| Dyne Therapeutics (DYN) |
United States |
$3.171B |
0.00 |
| Hypermarcas (HYPMY) |
Brazil |
$2.850B |
19.57 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$2.847B |
9.08 |
| Soleno Therapeutics (SLNO) |
United States |
$2.749B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$2.082B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$2.067B |
24.50 |
| Guardian Pharmacy Services (GRDN) |
United States |
$1.812B |
34.90 |
| Harrow (HROW) |
United States |
$1.758B |
107.89 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$1.621B |
96.25 |
| Oruka Therapeutics (ORKA) |
United States |
$1.522B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$1.514B |
7.50 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$1.501B |
0.00 |
| Ardelyx (ARDX) |
United States |
$1.429B |
0.00 |
| Relay Therapeutics (RLAY) |
United States |
$1.322B |
0.00 |
| Savara (SVRA) |
United States |
$1.316B |
0.00 |
| Xencor (XNCR) |
United States |
$1.263B |
0.00 |
| Enliven Therapeutics (ELVN) |
United States |
$1.218B |
0.00 |
| Nektar Therapeutics (NKTR) |
United States |
$1.165B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
United States |
$1.160B |
0.00 |
| Evotec AG (EVO) |
Germany |
$1.069B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
United States |
$0.988B |
0.00 |
| Cronos Group (CRON) |
Canada |
$0.946B |
0.00 |
| Esperion Therapeutics (ESPR) |
United States |
$0.935B |
0.00 |
| Theravance Biopharma (TBPH) |
United States |
$0.918B |
38.55 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.852B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.808B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.788B |
7.03 |
| ProKidney (PROK) |
United States |
$0.707B |
0.00 |
| Lexeo Therapeutics (LXEO) |
United States |
$0.690B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
United States |
$0.633B |
0.00 |
| Lyell Immunopharma (LYEL) |
United States |
$0.602B |
0.00 |
| Bioventus (BVS) |
United States |
$0.595B |
12.19 |
| Organogenesis (ORGO) |
United States |
$0.591B |
0.00 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$0.564B |
13.35 |
| Elite Pharmaceuticals (ELTP) |
United States |
$0.555B |
0.00 |
| Zevra Therapeutics (ZVRA) |
United States |
$0.494B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.440B |
6.03 |
| Akebia Therapeutics (AKBA) |
United States |
$0.430B |
0.00 |
| Galectin Therapeutics (GALT) |
United States |
$0.388B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.366B |
21.78 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.355B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$0.355B |
9.90 |
| Avalo Therapeutics (AVTX) |
United States |
$0.353B |
0.00 |
| Silence Therapeutics (SLN) |
United Kingdom |
$0.326B |
0.00 |
| Larimar Therapeutics (LRMR) |
United States |
$0.316B |
0.00 |
| Relmada Therapeutics (RLMD) |
United States |
$0.306B |
0.00 |
| Fractyl Health (GUTS) |
United States |
$0.306B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.298B |
0.00 |
| OmniAb (OABI) |
United States |
$0.286B |
0.00 |
| Pyxis Oncology (PYXS) |
United States |
$0.260B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.250B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$0.248B |
0.00 |
| Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.234B |
0.00 |
| Journey Medical (DERM) |
United States |
$0.223B |
0.00 |
| Protara Therapeutics (TARA) |
United States |
$0.221B |
0.00 |
| AleAnna (ANNA) |
United States |
$0.218B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.205B |
0.00 |
| Profound Medical (PROF) |
Canada |
$0.205B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.182B |
0.00 |
| Surrozen (SRZN) |
United States |
$0.175B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.167B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.160B |
0.00 |
| Cassava Sciences (SAVA) |
United States |
$0.155B |
0.00 |
| Gain Therapeutics (GANX) |
United States |
$0.153B |
0.00 |
| Incannex Healthcare (IXHL) |
Australia |
$0.150B |
0.00 |
| Unicycive Therapeutics (UNCY) |
United States |
$0.141B |
0.00 |
| Inhibikase Therapeutics (IKT) |
United States |
$0.108B |
0.00 |
| Vivani Medical (VANI) |
United States |
$0.106B |
0.00 |
| Avita Medical (RCEL) |
United States |
$0.105B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.100B |
0.00 |
| Cardiol Therapeutics (CRDL) |
Canada |
$0.099B |
0.00 |
| Context Therapeutics (CNTX) |
United States |
$0.097B |
0.00 |
| Prelude Therapeutics (PRLD) |
United States |
$0.092B |
0.00 |
| VAXART, INC (VXRT) |
United States |
$0.088B |
0.00 |
| Plus Therapeutics (PSTV) |
United States |
$0.087B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.086B |
31.30 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.080B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
United States |
$0.077B |
0.00 |
| Assertio Holdings (ASRT) |
United States |
$0.075B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.072B |
0.00 |
| Korro Bio (KRRO) |
United States |
$0.071B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.069B |
0.00 |
| Metagenomi (MGX) |
United States |
$0.068B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
United States |
$0.064B |
0.00 |
| Lite Strategy (LITS) |
United States |
$0.063B |
0.00 |
| PolyPid (PYPD) |
Israel |
$0.063B |
0.00 |
| Arch Biopartners (ACHFF) |
Canada |
$0.063B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
United States |
$0.062B |
0.00 |
| Dominari Holdings (DOMH) |
United States |
$0.061B |
0.00 |
| Talphera (TLPH) |
United States |
$0.060B |
0.00 |
| Nutriband (NTRB) |
United States |
$0.059B |
0.00 |
| Procaps Group, S.A (PROCF) |
Luxembourg |
$0.058B |
0.00 |
| BioNxt Solutions (BNXTF) |
Canada |
$0.055B |
0.00 |
| Wellgistics Health (WGRX) |
United States |
$0.055B |
0.00 |
| Century Therapeutics (IPSC) |
United States |
$0.050B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
United States |
$0.048B |
0.00 |
| Jupiter Neurosciences (JUNS) |
United States |
$0.039B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.039B |
0.00 |
| Mural Oncology (MURA) |
Ireland |
$0.035B |
0.00 |
| FibroGen (FGEN) |
United States |
$0.034B |
0.00 |
| Klotho Neurosciences (KLTO) |
United States |
$0.033B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.032B |
27.12 |
| Vyome Holdings (HIND) |
United States |
$0.032B |
0.00 |
| Inotiv (NOTV) |
United States |
$0.029B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.027B |
0.00 |
| Enlivex Therapeutics (ENLV) |
Israel |
$0.027B |
0.00 |
| Scienture Holdings (SCNX) |
United States |
$0.025B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.024B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.024B |
0.00 |
| Liminatus Pharma (LIMN) |
United States |
$0.023B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.020B |
0.00 |
| Vivos Therapeutics (VVOS) |
United States |
$0.019B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.019B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
United States |
$0.019B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.018B |
0.00 |
| Mannatech (MTEX) |
United States |
$0.018B |
0.00 |
| Traws Pharma (TRAW) |
United States |
$0.017B |
0.02 |
| Heatwurx (PCSA) |
United States |
$0.016B |
0.00 |
| Cosmos Health (COSM) |
United States |
$0.016B |
0.00 |
| Mangoceuticals (MGRX) |
United States |
$0.016B |
0.00 |
| BioLineRx (BLRX) |
Israel |
$0.014B |
0.00 |
| Tempest Therapeutics (TPST) |
United States |
$0.014B |
0.00 |
| Curanex Pharmaceuticals Inc (CURX) |
United States |
$0.013B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
United States |
$0.013B |
0.00 |
| VYNE Therapeutics (VYNE) |
United States |
$0.012B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
United States |
$0.012B |
0.00 |
| BioVie (BIVI) |
United States |
$0.012B |
0.00 |
| CASI Pharmaceuticals (CASI) |
China |
$0.011B |
0.00 |
| Ainos (AIMD) |
United States |
$0.011B |
0.00 |
| Ernexa Therapeutics (ERNA) |
United States |
$0.010B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.010B |
0.00 |
| Alaunos Therapeutics (TCRT) |
United States |
$0.010B |
0.00 |
| Aptorum Group (APM) |
United Kingdom |
$0.008B |
0.00 |
| Nuvilex (PMCB) |
United States |
$0.008B |
0.00 |
| TransCode Therapeutics (RNAZ) |
United States |
$0.008B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
United States |
$0.008B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
Israel |
$0.008B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.007B |
0.00 |
| Lyra Therapeutics (LYRA) |
United States |
$0.007B |
0.00 |
| ProPhase Labs (PRPH) |
United States |
$0.006B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.006B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.006B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.005B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
United States |
$0.005B |
0.00 |
| Indaptus Therapeutics (INDP) |
United States |
$0.005B |
0.00 |
| XORTX Therapeutics (XRTX) |
Canada |
$0.005B |
0.00 |
| Clearmind Medicine (CMND) |
Canada |
$0.004B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.004B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.004B |
0.00 |
| InMed Pharmaceuticals (INM) |
Canada |
$0.004B |
0.00 |
| CDT Equity (CDT) |
United States |
$0.003B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.003B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
China |
$0.003B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.002B |
0.00 |
| PainReform (PRFX) |
Israel |
$0.002B |
0.00 |
| Aditxt (ADTX) |
United States |
$0.002B |
0.00 |
| SciSparc (SPRC) |
Israel |
$0.001B |
0.00 |
| Emisphere Technologies (EMIS) |
United States |
$0.000B |
0.00 |
| Indivior (INDV) |
United States |
$0.000B |
18.67 |
| 4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
| Minerva Neurosciences (NERV) |
United States |
$0.000B |
0.00 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
